COVID vaccine induces robust T cell responses in blood cancer patients

Researchers have found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

Leave A Comment

Your email address will not be published. Required fields are marked *